COVID-19: The Need for Immunoprevention at Industrial Scale.

Halstead, Scott B

Halstead, Scott B.

Halstead SB; Consultant, North Bethesda, Maryland.

Am J Trop Med Hyg ; 102(6): 1151, 2020 06.

Article in English | MEDLINE | ID: covidwho-601575

Subject(s)

Betacoronavirus/pathogenicity; Coronavirus Infections/prevention & control; Immunotherapy/methods; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Viral Vaccines/therapeutic use; Antibodies, Monoclonal/biosynthesis; Antibodies, Monoclonal/isolation & purification; Antibodies, Monoclonal/therapeutic use; Antiviral Agents/chemical synthesis; Antiviral Agents/therapeutic use; Betacoronavirus/drug effects; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Clinical Laboratory Techniques/statistics & numerical data; Coronavirus Infections/diagnosis; Coronavirus Infections/drug therapy; Coronavirus Infections/epidemiology; Humans; Immune Sera/chemistry; Immune Sera/pharmacology; Pneumonia, Viral/diagnosis; Pneumonia, Viral/drug therapy; Pneumonia, Viral/epidemiology; SARS-CoV-2; United States/epidemiology; Viral Vaccines/biosynthesis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus / Immunotherapy Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Am J Trop Med Hyg Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google